Navigation Links
Ranbaxy Gets USFDA Nod For Simvastatin

Pharma major Ranbaxy Laboratories Ltd has received approval from the USFDA for manufacturing and marketing cholesterol-lowering Simvastatin Tablets in the US market. //

The company said it has received the approval for marketing the drug in strengths of 80mg with 180 day exclusivity.

Simvastatin, currently marketed as 'Zocor' in the US, has been found to be bioequivalent by the FDA Office of Generic Drugs. The total annualized market sales for Simvastatin is 4.6 billion dollars, out of which the 80mg strength accounts for 513 million dollars.

"We anticipate significant benefits and value from our Simvastatin formulation to both patients and prescribers," Ranbaxy CEO and Managing Director Malvinder Mohan Singh said.

The drug is indicated in the treatment of patients with coronary heart disease, hypercholesterolemia requiring modifications of lipid profiles and adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH).

"We expect to launch Simvastatin 80mg on an exclusive basis immediately. We believe that by offering an affordably priced generic alternative, we will have a positive impact on the cost of healthcare for patients who have or are at high risk of coronary heart disease," Ranbaxy Pharmaceuticals Inc Vice President of sales and marketing Jim Meehan said.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ranbaxy Gets USFDA Nod For Simvastatin

(Date:8/23/2014)... The report “Polycarbonate Resin Market by ... 2018” defines and segments the global polycarbonate resin ... revenue and consumption. It also identifies driving and ... with analysis of trends, opportunities, burning issues, winning ... revenues are forecasted on the basis of major ...
(Date:8/23/2014)... According to the new research report, "Electronic Adhesives ... Regional Trends & Forecast to 2019," defines and ... and forecast of value individually. Along with this, ... applications and geography are also discussed in the ... 26 figures spread through 234 pages and in-depth ...
(Date:8/23/2014)... 2014 A team of New York researchers ... when preceded by surgery and delivered by an experienced team. ... study. Click here to read it now . ... cases of mesothelioma patients who underwent hemithoracic (one side ... to the shape of a tumor. Patients who had ...
(Date:8/23/2014)... NY (PRWEB) August 23, 2014 On ... reported on a data breach suffered by Community ... saw the compromise of 4.5 million records containing Personally ... security numbers. According to Mandiant, who was engaged to ... from an advanced group of cyber attackers based ...
(Date:8/23/2014)... 23, 2014 Professional kitchen employees, prospective ... aid in preparing for Food Safety Certification exams thanks ... by Dynamic Path. , Dynamic Path announced the release ... more than 200 review questions for culinary industry students ... to cover requirements of the ServSafe® Food Safety Certification, ...
Breaking Medicine News(10 mins):Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 3Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 4Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 3Health News:New Study Links Hospital Experience and Prior Surgery with Mesothelioma Radiation Success, According to Surviving Mesothelioma 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 3Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 4Health News:Food Handler Safety Certification Made Easy with Dynamic Path 2
... 2008 Kent State University public,relations students organized a ... need for organ donors. April is National Donate Life ... flash mob is defined as: "A large group of ... unusual action for a brief period of,time, then quickly ...
... FDA for proposing less governance of the practice ... and Drug Administration draft guidelines for oversight of off-label ... drugs for unapproved uses, one expert contends. , The ... Dr. Randall Stafford, an associate professor of medicine at ...
... Researchers note invasive surgery is currently the most common ... A topical cream appears to be a highly effective ... report. , Rather than directly targeting the disease itself, ... system fight off the human papillomavirus (HPV) -- which ...
... between best and worst states, with Vermont on top and ... -- For American children, where they are born and raised ... staying healthy and living to adulthood, a new report finds. ... the States , from the Every Child Matters Education Fund, ...
... are more likely to tolerate discrimination than women, however ... immigrants and Arab-American airplane travelers, according to a study ... and Politics. , In a survey of more ... Law and USC College found that both men and ...
... critical health,infrastructure, WASHINGTON, April 2, 2008 ... well determine a major,part of the future course ... president and CEO of the Association of Academic ... the Americas, Asia,Europe, and the Mideast at the ...
Cached Medicine News:Health News:Kent State Public Relations Students Host a Flash Mob to Launch National Donate Life Month 2Health News:Off-Label Drug Use Needs Strong Oversight 2Health News:Topical Cream Treats Precancerous Lesions of Vulva 2Health News:Topical Cream Treats Precancerous Lesions of Vulva 3Health News:Report Finds Big Disparities in Well-Being of U.S. Kids 2Health News:Report Finds Big Disparities in Well-Being of U.S. Kids 3Health News:Report Finds Big Disparities in Well-Being of U.S. Kids 4Health News:Study finds that discrimination varies by gender and race 2Health News:Study finds that discrimination varies by gender and race 3Health News:Academic Health Centers Major Force in Global Knowledge Economy 2
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... HOUSTON , Aug. 21, 2014   Memorial Hermann ... Anderson Cancer Center today announced a new partnership to ... network of community breast care centers in the greater ... November, MD Anderson will become the exclusive provider of professional ... care centers, located in Memorial City, The Woodlands ...
(Date:8/21/2014)... Ill. , Aug. 21, 2014 ... Baxter International Inc. today announced positive results from ... 855, an investigational, extended half-life recombinant factor VIII ... [Antihemophilic Factor (Recombinant)], which met its primary endpoint ... prophylaxis arm compared to the on-demand arm. ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
... LLC is pleased to announce that it has been ... Human Research Protection Programs (AAHRPP) at the September meeting ... in the Kansas City metro area, Mid*Lands is an ... welfare of research study participants. Mid*Lands IRB specializes in ...
... More than 1,700 medical device and diagnostics ... 24 countries and 33 states – attended the ... MedTech Conference this week in Washington, D.C. ... (Photo:   http://www.newscom.com/cgi-bin/prnh/20101022/DC86995-a ) ...
Cached Medicine Technology:Mid*Lands IRB, LLC - First Independent IRB in Kansas and the Kansas City Area Awarded Accreditation for Protecting Research Participants 2AdvaMed 2010 Sets New Attendance Record: More than 1,700 Device and Diagnostics Leaders from Across the Country and Around the World Came to Washington, D.C. 2
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca...
... Rapid Immunoassay: Uni-Gold Recombigen HIV is a single ... to HIV-1 in plasma, serum and whole blood ... in point of care settings as an aid ... is suitable for use in appropriate multi-test algorithms ...
... The advanced performance ... have been applied to ... Reduction Implants) Upper Extremity ... rigidity combine to provide ...
... CHS System takes the time proven technology ... ,The VHS® Supracondylar Cable Plate is designed ... femur fractures including periprosthetic fractures. The combination ... angle of the barrel and the plate ...
Medicine Products: